ATOS - Atossa Therapeutics Inc
IEX Last Trade
1.38
0.010 0.725%
Share volume: 548,007
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.37
0.01
0.73%
Summary score
22%
Profitability
18%
Dept financing
3%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-53.63%
Return on assets
-32.19%
Return on sales
0%
Return on invested capital
-531.01%
Total debt ratio
18.46%
Debt ratio change over timeo
-0.89%
Current Ratio
7.15%
Quick Ratio
0%
Cash Position Ratio
6.44%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-28.87%
Return on assets
-25.34%
Return on sales
0%
Return on invested capital
272.01%
Total debt ratio
11.12%
Debt ratio change over timeo
-0.97%
Current Ratio
9.92%
Quick Ratio
0%
Cash Position Ratio
8.5%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-46.64%
Return on assets
-38.56%
Return on sales
0%
Return on invested capital
232.14%
Total debt ratio
17.94%
Debt ratio change over time
-0.95%
Current Ratio
5.51%
Quick Ratio
0%
Cash Position Ratio
4.15%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-132.7%
Return on assets
-118.79%
Return on sales
0%
Return on invested capital
361.2%
Total debt ratio
-89.15%
Debt ratio change over time
-0.89%
Current Ratio
2.65%
Quick Ratio
0%
Cash Position Ratio
2.33%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ATOS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -53.63% | -3.05% | 11.55% | 6.27% |
| Return on assets | -32.19% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -531.01% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 18.46% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.89% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 9.92% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.5% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 18% | 40% | 41% |
| Short-term ratios | ATOS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -28.87% | -25.62% | 17.94% | 7.14% |
| Return on assets | -25.34% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 272.01% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 11.12% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.97% | -23.44% | 9.66% | 0.6% |
| Dept financing | 3% | 25% | 45% | 8% |
| Current Ratio | 9.92% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.5% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 27% | 22% | 38% |